Abstract:Background Sinonasal teratocarcinosarcomas (SNTCS) are rare sinonasal malignancies, the incidence of which is less-than 1% of all tumors. There is limited data available on SNTCS's, often as case reports and small case series. The management of SNTCS is complicated because of its location, locally aggressive biology, difficulty in achieving complete resection, and limited data on chemotherapy in these malignancies. This audit was performed to understand the role of neoadjuvant chemotherapy (NACT) in SNTCS's, its ability to downstage the disease, achieve complete resection, and impact on long-term survival outcomes. Methods This was a retrospective analysis of a prospectively maintained database approved by the Institutional Ethics Committee (IEC). The baseline characteristics, the extent of tumor, Kadish stage, NACT regimen, and adverse events were extracted from the Electronic Medical Records and the patient's case file. Patients with baseline extensive/inoperable disease were referred for NACT from the multidisciplinary joint clinic followed by response assessment (RECIST v1.1). Patients underwent skull-base surgery if resectable post-completion of NACT, however, if deemed unresectable were treated with non-surgical modalities or palliative therapies. Results The data of 27 patients were evaluated from the year 2015 to 2022. The median age was 42 years (IQR:30-56) and 85.2% (n=23) were males. The ECOG-PS was 0-1 in 88.8% (n=24) patients. All 27 patients received NACT in view of extensive disease at presentation. 74.1% (n=20) patients received Cisplatin-Etoposide and 25.9% (n=7) received other chemotherapy regimens. The median number of chemotherapy cycles was 2(IQR:2-3). 96.3% patients (n=26) completed the planned NACT cycles. 70.4% (n=19) patients achieved a partial response in post-NACT imaging. 77.8% (n=18) underwent surgery, 18.5% (n=5) received CTRT, and 7.4% (n=2) received definitive-RT alone. The median PFS and OS of the cohort was 19months (95%CI:12.0-25.6) and 23months (95%CI:5.94-40.06) respectively. Conclusion NACT is safe, feasible, and effective with significant response rates, leading to effective downstaging, resectability and improved survival in patients with locally advanced SNTCS's.

NASOPHARYNGEAL CARCINOMA: A CHANGING TREND IN EPIDEMIOLOGY ,INCIDENCE RATE AND TREATMENT PROSPECTS IN TERTIARY CARE HOSPITAL

Current trend of surgery in juvenile nasopharyngeal angiofibroma: a hospital based retro-prospective study

Clinical Analysis of Nasal and Laryngeal Neuroendocrine Carcinoma

Metastatic nasopharyngeal carcinoma presenting with palpable neck nodes-A look at clinical presentation and literature review on screening

Nasopharyngeal adenocarcinoma: A population-based analysis

A Rare Nasopharyngeal Adenoid Cystic Carcinoma: Case Report and Literature Review

Nasopharyngeal Carcinoma with Particular Characteristics: Case Report.

Epidemiological Profile and Clinicopathological, Therapeutic, and Prognostic Characteristics of Nasopharyngeal Carcinoma in Northern Morocco

Epidemiological and Histopathological Analysis of Head and Neck Cancers in Northern India- A Retrospective Review

Adenoid Cystic Carcinoma of the Nasopharynx: A Retrospective Study of 12 Cases

Neoadjuvant chemotherapy in locally advanced Sinonasal Teratocarcinosarcoma a rare malignancy - an audit from an academic Tertiary Care Centre in India

Carcinoma of the nasopharynx in young patients

Nasopharyngeal Carcinoma (NPC): Strong suspicion in persistent otitis media with effusion

Carcinoma stomach in Eastern India-An audit from a tertiary health care center

Adenoid Cystic Carcinoma of the Nasopharynx with Skull Base Involvement: Retrospective National Cohort Analysis of Treatment Paradigms, Outcomes, and Provider Density

Management of recurrent nasopharyngeal carcinoma: current perspectives

Survival in Head and Neck Cancers - Results of A Multi- Institution Study

[Advances in Nasopharyngeal Carcinoma Treatment: Induction Chemotherapy and Concomitant Radio-Chemotherapy].

Cancer incidence among patients attending a tertiary care cancer hospital in central India – A retrospective study

[New developments in the management of nasopharyngeal carcinoma]

Enhanced MRI Radiomics Based Model for Predicting Recurrence or Metastasis of Nasopharyngeal Cancer (NC) Undergoing Concurrent Chemoradiotherapy: A Retrospective Study